Modulation of signaling through GPCR-cAMP-PKA pathways by PDE4 depends on stimulus intensity: Possible implications for the pathogenesis of acrodysostosis without hormone resistance-Reference-Cited by-同舟云学术

Modulation of signaling through GPCR-cAMP-PKA pathways by PDE4 depends on stimulus intensity: Possible implications for the pathogenesis of acrodysostosis without hormone resistance

Published:2017-02 Issue: Volume:442 Page:1-11
ISSN:0303-7207
Container-title:Molecular and Cellular Endocrinology
language:en
Short-container-title:Molecular and Cellular Endocrinology

Author:

Motte Emmanuelle,Le Stunff Catherine,Briet Claire,Dumaz Nicolas,Silve Caroline

Funder

INSERM

Ligue Contre le Cancer Comité de Paris

GEFLUC Paris-Ile-de-France

fondation ARC pour la recherche sur le cancer (ND)Fondation ARC pour la Recherche sur le Cancer

La Société Française d'Endocrinologie (SFE)

Sanofi Aventis and La Fondation pour la Recherche Médicale (FRM)

Publisher

Elsevier BV

Subject

Endocrinology,Molecular Biology,Biochemistry

Reference42 articles.

1. Relative quantitation of gene expression;ABI-PRISM-7700-Sequence-Detection-System;User Bull.,2001

2. Compartmentalized signalling: spatial regulation of cAMP by the action of compartmentalized phosphodiesterases;Baillie;FEBS J.,2009

3. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors;Beavo;Trends Pharmacol. Sci.,1990

4. PDE4D and PDE4B function in distinct subcellular compartments in mouse embryonic fibroblasts;Blackman;J. Biol. Chem.,2011

5. Critical role of PDE4D in beta2-adrenoceptor-dependent cAMP signaling in mouse embryonic fibroblasts;Bruss;J. Biol. Chem.,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphodiesterase 4D activity in acrodysostosis-associated neural pathology: too much or too little?;Brain Communications;2024

2. Daily exposure to low concentrations Tetrabromobisphenol A interferes with the thyroid hormone pathway in HepG2 cells;Fundamental Research;2023-05

3. Identification of phosphodiesterase-4 as the therapeutic target of arctigenin in alleviating psoriatic skin inflammation;Journal of Advanced Research;2021-11

4. DC591017, a phosphodiesterase-4 (PDE4) inhibitor with robust anti-inflammation through regulating PKA-CREB signaling;Biochemical Pharmacology;2020-07

5. Genetic disorders caused by mutations in the parathyroid hormone/parathyroid hormone–related peptide receptor, its ligands, and downstream effector molecules;Principles of Bone Biology;2020